Balentine LLC Abbott Laboratories Transaction History

Balentine LLC

$2.3 Billion
Q4 2024

A detailed history of Balentine LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Balentine LLC holds 5,585 shares of ABT stock, worth $758,554. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,585

Previous 8,296 32.68%

Holding current value

$758,554

Previous $945,000 33.23%

% of portfolio

0.03%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$111.93 - $119.39 $303,442 - $323,666	-2,711 Reduced 32.68%	5,585 $631,000
Q3 2024 Oct 30, 2024	BUY	$100.07 - $118.13 $271,489 - $320,486	2,713 Added 48.59%	8,296 $945,000
Q2 2024 Aug 07, 2024	SELL	$100.73 - $112.44 $1.17 Million - $1.31 Million	-11,649 Reduced 67.6%	5,583 $580,000
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $128,357 - $141,765	-1,172 Reduced 6.37%	17,232 $1.96 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $432,190 - $529,036	-4,792 Reduced 20.66%	18,404 $2.03 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $19,583 - $23,497	-205 Reduced 0.88%	23,196 $2.25 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $71,856 - $80,062	-713 Reduced 2.96%	23,401 $2.55 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $590,749 - $695,346	-6,099 Reduced 20.19%	24,114 $2.44 Million
Q4 2022 Jan 31, 2023	BUY	$95.06 - $111.52 $492,981 - $578,342	5,186 Added 20.72%	30,213 $3.32 Million
Q3 2022 Oct 26, 2022	SELL	$96.76 - $112.03 $828,846 - $959,648	-8,566 Reduced 25.5%	25,027 $2.42 Million
Q2 2022 Oct 26, 2022	BUY	$102.07 - $123.37 $931,694 - $1.13 Million	9,128 Added 37.31%	33,593 $3.65 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $3.43 Million - $4.14 Million	33,593 New	33,593 $3.65 Million
Q1 2022 Oct 26, 2022	SELL	$114.02 - $139.04 $1.04 Million - $1.27 Million	-9,128 Reduced 27.17%	24,465 $2.9 Million
Q4 2021 Oct 26, 2022	SELL	$115.53 - $141.46 $1.64 Million - $2.01 Million	-14,186 Reduced 42.23%	19,407 $2.73 Million
Q4 2021 Feb 02, 2022	SELL	$115.53 - $141.46 $1.33 Million - $1.62 Million	-11,484 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $375,061 - $414,927	3,215 Added 38.88%	11,484 $1.36 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $4,443 - $5,230	-42 Reduced 0.51%	8,269 $959,000
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $11,210 - $13,207	-103 Reduced 1.22%	8,311 $996,000
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $29,925 - $32,609	285 Added 3.51%	8,414 $921,000
Q3 2020 Nov 02, 2020	BUY	$91.64 - $111.29 $514,558 - $624,893	5,615 Added 223.35%	8,129 $885,000
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $128,714 - $164,738	1,681 Added 201.8%	2,514 $230,000
Q1 2020 May 18, 2020	SELL	$62.82 - $91.86 $59,113 - $86,440	-941 Reduced 53.04%	833 $66,000
Q4 2019 Sep 02, 2020	BUY	$78.51 - $87.4 $82,199 - $91,507	1,047 Added 144.02%	1,774 $154,000
Q3 2019 Nov 15, 2019	SELL	$81.84 - $88.74 $7,283 - $7,897	-89 Reduced 10.91%	727 $61,000
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $20,989 - $24,480	288 Added 54.55%	816 $69,000
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $32,107 - $38,734	528 New	528 $39,000
Q1 2018 May 16, 2018	SELL	$56.27 - $63.62 $91,720 - $103,700	-1,630 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$48.06 - $53.64 $78,337 - $87,433	1,630	1,630 $87,000

Others Institutions Holding ABT

# of Institutions

3,363

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $238B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account